Retrophin shares are up 32% in premarket following an announcement that the company has reached two non-dilutive financing deals worth up to $80 million in total . Per the press release, Retrophin agreed to a $40 million senior secured term loan facility with Athyrium Capital Management in one d...
Today"s Top Stories in Health Care: Inovio Pharmaceuticals, MannKind Corp ...
No comments:
Post a Comment